NEW YORK (360Dx) – Zenosense on Wednesday announced that its joint venture called MIDS Medical has reached an agreement for up to $1.2 million in funding to further develop its handheld device for the early detection of a heart attack at the point of care.
To read the full story....
...and receive Daily News bulletins.
Already have a 360Dx or GenomeWeb account?
Login Now.
Don't have a 360Dx or GenomeWeb account?
Register for Free.